Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Virology
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1429808
This article is part of the Research Topic Transmission and Infection of Arboviruses – Volume II View all 4 articles

Development and evaluation of two rapid lateral flow assays for on-site detection of African swine fever virus

Provisionally accepted
Lihua Wang Lihua Wang 1*Juhun Kim Juhun Kim 2*Hyangju Kang Hyangju Kang 2*Hong-Je Park Hong-Je Park 3*Min-Jong Lee Min-Jong Lee 3*Sung-Hee Hong Sung-Hee Hong 4*Chang-Won Seo Chang-Won Seo 4*Rachel Madera Rachel Madera 5*Yuzhen Li Yuzhen Li 5*Aidan Craig Aidan Craig 5*Jamie Retallick Jamie Retallick 6*Franco Matias Ferreyra Franco Matias Ferreyra 6Eun-Ju Sohn Eun-Ju Sohn 2*Jishu Shi Jishu Shi 1*
  • 1 Department of Anatomy and Physiology, Kansas State University, Manhattan, United States
  • 2 BioApplications Inc., Pohang, Republic of Korea
  • 3 Other, Gyeonggi-do, Republic of Korea
  • 4 Celltrix Co, Seongnam-si, Gyeonggi-do, Republic of Korea
  • 5 Kansas State University, Manhattan, Kansas, United States
  • 6 Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, Kansas, United States

The final, formatted version of the article will be published soon.

    Introduction: African swine fever (ASF) is a lethal and highly contagious transboundary animal disease with the potential for rapid international spread. In the absence of widely available and definitively proven vaccinesafe and effective vaccine, rapid and early detection is critical for ASF control. The quick and user-friendly lateral flow assay (LFA) can easily be performed by following simple instruction, and is ideal for on-site use. This study describes the development and validation of two LFAs for rapid detection of ASF virus (ASFV) in pig serum.The highly immunogenic antigens (p30 and p72) of ASFV Georgia 2007/1 (genotype II) were expressed in plants (Nicotiana benthamiana) and were used to immunize BALB/c mice to generate specific monoclonal antibodies (mAbs) against p30 and p72 proteins. These mAbs with the strongest binding ability to each protein were employed to develop p30_LFA and p72_LFA for detecting the respective ASFV antigens. The assays were first evaluated using a spike-in test by adding the purified p30 or p72 protein into serum sample from a healthy donor pig. Further validation of the tests was carried out using serum samples derived from experimental infected domestic pigs, field domestic pigs and feral pigs, and the results were compared with those of ASFV real-time PCR.Results: p30_LFA and p72_LFA showed no cross-reaction with common swine viruses and delivered visual results in 15 minutes. When testing with serially diluted proteins in swine serum samples, analytical sensitivity reached 10 ng/test for p30_LFA and 20 ng/test for p72_LFA. Using real-time PCR as a reference, both assays demonstrated high sensitivity (84.2180% for p30_LFA, 100% for p72_LFA) with experimentally ASFV infected pig sera. Specificity was 100% for both LFAs using a panel of PBS inoculated domestic pig sera. Excellent specificity also showed for field domestic pig sera (100% for p30_LFA, 93% for p72_LFA) and feral pig sera (100% for both LFAs).The results obtained in this study suggest that p30_LFA and p72_LFA hold promise as rapid, sensitive, user-friendly, and field-deployable diagnostic tools for ASF control, particularly in settings with limited laboratory resources.

    Keywords: African Swine Fever, Lateral flow assay, rapid, Sensitive, development, Validation Font: Italic Indent: Left: 0", Hanging: 0.39", Space Before: 18 pt Formatted: Indent: Left: 0"

    Received: 08 May 2024; Accepted: 06 Aug 2024.

    Copyright: © 2024 Wang, Kim, Kang, Park, Lee, Hong, Seo, Madera, Li, Craig, Retallick, Matias Ferreyra, Sohn and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lihua Wang, Department of Anatomy and Physiology, Kansas State University, Manhattan, United States
    Juhun Kim, BioApplications Inc., Pohang, Republic of Korea
    Hyangju Kang, BioApplications Inc., Pohang, Republic of Korea
    Hong-Je Park, Other, Gyeonggi-do, Republic of Korea
    Min-Jong Lee, Other, Gyeonggi-do, Republic of Korea
    Sung-Hee Hong, Celltrix Co, Seongnam-si, Gyeonggi-do, Republic of Korea
    Chang-Won Seo, Celltrix Co, Seongnam-si, Gyeonggi-do, Republic of Korea
    Rachel Madera, Kansas State University, Manhattan, 66506, Kansas, United States
    Yuzhen Li, Kansas State University, Manhattan, 66506, Kansas, United States
    Aidan Craig, Kansas State University, Manhattan, 66506, Kansas, United States
    Jamie Retallick, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, 66506, Kansas, United States
    Eun-Ju Sohn, BioApplications Inc., Pohang, Republic of Korea
    Jishu Shi, Department of Anatomy and Physiology, Kansas State University, Manhattan, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.